An Effective Oral Tablet For COVID-19? Armand Balboni, MD, PhD Discusses

Finding Genius Podcast

Richard Jacobs

Medicine, Health & Fitness

4.4 • 1K Ratings

🗓️ 1 October 2020

⏱️ 30 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Efforts to stop SARS-CoV-2 in its tracks have been ongoing for months, and now there might be something tangible that makes it happen.

Press play to learn:

How to trigger viral mutations that prevent SARS-CoV-2 from replicating in the human body, thereby preventing the "cytokine storm" associated with COVID-19
COVID-19 prophylaxis in communities that may need it the most? Whether it's possible, and how it's being investigated
What's necessary in order to warrant emergency use authorization for an antiviral drug in treating COVID-19

Fueled by a long-standing fascination with infectious diseases and pandemics like the Black Death, Dr. Armand Balboni earned a dual MD/PhD degree at Mount Sinai School of Medicine in New York. Having spent 17 years in the US military as an officer working on a number of infectious diseases including Ebola, dengue fever, and malaria, he discovered unmet needs in the marketplace, and wanted to design a socially-conscious company to meet those needs. In 2014, this goal manifested as Appili Therapeutics, a pure play anti-infectives company.

Today, the team at Appili Therapeutics is working on phase II and phase III clinical trials for the most advanced product that is an oral tablet for COVID-19: an antiviral medication called favipiravir. This medication has already undergone three phase III clinical trials in the US and been approved for pandemic flu in Japan and China. The expectation is that the current phase II and phase III clinical trials will show that favipiravir is safe and effective specifically for the treatment of COVID-19. Dr. Balboni anticipates that this medication will be available for use against COVID-19 by early next year.

Dr. Balboni explains the importance of each stage in the US clinical trial process, the specific mechanism of action by which favipiravir works against viral replication, Operation Warp Speed as it applies to both vaccines and therapeutic drugs, possible side effects of favipiravir, and more.

Visit https://clinicaltrials.gov/ and https://www.appilitherapeutics.com/ for more information.

Available on Apple Podcasts: apple.co/2Os0myK

Transcript

Click on a timestamp to play from that location

0:00.0	Forget frequently asked questions common sense common knowledge or Google how about advice from a real genius
0:06.8	95% of people in any profession are good enough to be qualified and licensed 5% go and beyond. They become very good at what they do.
0:15.1	But only 0.1% are real Jesus.
0:18.3	Richard Jacobs has made it his life's mission to find them for you.
0:22.4	He hunts down and interviews geniuses in every field, sleep science, cancer, stem cells,
0:27.2	ketogenic diets, and more.
0:28.8	Here come the geniuses.
0:30.4	This is the Finding Genius Podcast.
0:33.0	That is Richard Jacobs.
0:35.0	Hello, this is Richard Jacobs with the Finding Genius Podcast.
0:41.0	I have Armand Boboni. he's a as an MD at a PhD he is the CEO of a Pillai
0:46.2	therapeutics and we're gonna talk about a new drug that they're coming out with I
0:51.6	don't even know if I could pronounce it right. It's a
0:53.6	the Vivapirir I hope that's how it's pronounced. It has implications on COVID. So
0:59.0	come on, thanks for coming. No, great to be here and thanks for having me.
1:04.5	And importantly, you both have a peer review and a pill eye, correct?
1:07.5	Oh, good.
1:08.5	Do you guys abbreviate the name and call it like Favi around the office or anything?
1:14.0	We don't. There is a drug name though for it.
1:18.0	We can use that as well. It's called Abagam.
1:20.0	But Faber Pirav is is the drug unfortunately for most of us.
1:26.2	And I think the name gives some of its function right? The veers like
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Richard Jacobs, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Richard Jacobs and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.